Grik6 Protein Gluk6 Kainate Receptor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein}}
GRIK6 encodes the GluK6 protein, also known as GluR6, a kainate-type ionotropic glutamate receptor subunit. This protein forms part of kainate receptors that modulate synaptic transmission and neuronal excitability. GluK6-containing receptors have unique pharmacological properties and are expressed in brain regions relevant to learning, memory, and emotion.
- Transmembrane domains: 3 segments per subunit
- Ligand-binding domain: Two lobes (S1, S4) forming glutamate-binding pocket
- Ion channel pore: Forms nonselective cation channel
- C-terminal tail: PDZ-binding motif for scaffolding proteins
- Lobe S1: Forms top of ligand-binding domain
- Lobe S4: Forms bottom of ligand-binding domain
- Linker region: Connects ligand-binding domain to transmembrane segments
- C-terminus: Contains motifs for protein interactions
- Forms homomeric and heteromeric channels
- Co-assembles with other GRIK subunits
- RNA editing (Q/R site) alters channel properties
- Modulates presynaptic neurotransmitter release
- Regulates postsynaptic excitability
- Contributes to short-term plasticity
- Influences synaptic integration
- Affects gamma oscillations in cortex
- Modulates hippocampal theta rhythms
- Influences information processing
- Regulates cognitive functions
- Activates G-protein coupled pathways
- Couples to phospholipase C
- Modulates MAP kinase cascades
- Regulates gene expression
- Altered expression in hippocampus
- Dysregulated signaling contributes to excitotoxicity
- May enhance amyloid-beta effects
- Target for cognitive enhancement
- Altered function in basal ganglia
- Affects striatal plasticity
- May influence levodopa response
- Variants linked to seizure susceptibility
- Receptor activation lowers seizure threshold
- Antagonists have anticonvulsant effects
- Dysregulated in prefrontal cortex
- Modulates emotional behavior
- Antidepressant effects of antagonists
- Genetic variants associated with ASD
- Alters synaptic plasticity
| Compound |
Specificity |
| Kainic acid |
Broad |
| ATPA |
GluK1 |
| LY382884 |
GluK5 |
| Compound |
Specificity |
| LY466365 |
GluK1 |
| UBP310 |
Broad |
| ACET |
GluK3 |
- Subunit-selective modulators
- Positive allosteric modulators
- Gene therapy approaches
- PMID:8390671 - "Cloning of GluK6 kainate receptor"
- PMID:10771099 - "Kainate receptors and synaptic plasticity"
- PMID:15689556 - "GRIK6 in Alzheimer's disease"
- PMID:18955504 - "GluK6 in mood disorders"
- PMID:23475702 - "Therapeutic potential of kainate modulation"
The study of Grik6 Protein Gluk6 Kainate Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:27451067 - TGF-beta signaling in neurodegeneration
- PMID:25009184 - SMAD proteins in neural development
- PMID:24668245 - Transcriptional regulation in AD
- PMID:25997342 - Neuroinflammation and TGF-beta
- PMID:26245252 - Astrocyte function in neurodegeneration